The infection control solution

Safe. Simple. Efficient.



Safe. Simple. Efficient.
Highlights
Spindiag completes EU market approval for Rhonda PCR rapid COVID-19 test
CE-IVD certification of rapid test successfully completed Mini-laboratory delivers results in about 40 minutes at [...]
Spindiag erhält EU-Marktzulassung für Rhonda Corona PCR-Schnelltest
Erfolgreiche Zertifizierung des PCR-basierten Schnelltests gemäß CE-IVD Mini-Labor liefert Ergebnisse in etwa 40 Minuten direkt [...]
The challenge


Infectious diseases


Waiting for lab results


Risk of infection
The point-of-care solution to control infectious diseases…
providing results for 60 patients per device right at the patient admission every day. Seven days a week.


Safe
Simple
No sample prep, no pipetting, no additional reagents: from swab to decision in approximately 40 minutes. Decide on the spot: quarantine or not.
Efficient
Centrifugal microfluidic technology
Rhonda disk
Insert a standard Copan ESwab®. Follow your usual routines.
Ultrafast and sensitive PCR for fast and reliable results.
Affordable even for screening applications.


Rhonda player
Three buttons, no touch. Simple is back.
One or two disks? Same or different patients? Modular by design!
One player for numerous applications. Introducing the Rhonda platform.


“I think this system particularly makes sense in intermediate care wards. From my own experience, if a patient is admitted to the hospital and the history indicates previous MRSA or 4MRGN, it’s useful to know within half an hour whether I need to isolate the patient and initiate further steps.”
“In my experience, the system is very useful and very helpful, especially with the functions I saw. It saves a lot of effort and time, in terms of days and beds – just what Spindiag designed it for. The system is a really good idea! I didn’t know this was technically possible. Awesome!”
“Spindiag´s system makes a lot of sense. I witness it myself: In the hospital, two patients are kept together, and late in the process it turns out that one patient has a pathogen. With such a system, you could recognise much faster: You need to isolate the patient.”
“The system is very useful! Since we receive many patients from external hospitals, we must isolate them on arrival. This costs a lot of time and money for everyone. In our case, it is meaningful to get the test result within half an hour.”
“This system makes a lot of sense and saves a lot of work, since you find out in only 30 minutes if the patient needs to be isolated or not!”
Who we are


Founded in 2016 as a spin-off from the prestigious German research institute Hahn-Schickard, Spindiag comprises a team of experienced physicists, engineers, molecular biologists, and entrepreneurs supported by a seasoned team of advisors with business experience in the diagnostic field.
In 2020, we launched a point-of-care PCR rapid test for the detection of SARS-CoV-2. The video illustrates the pandemic situation that threatened the world, and the solution that Spindiag is offering. It showcases the complete workflow from sample collection to result.
Enjoy our video here!
In 2018 we participated in the competition by the European Institute of Innovation and Technology (EIT). As a result for being in the final, we presented our company in this video. It shortly explains the downside of today’s situation of antibiotic resistance in hospitals inside of the European Union and the operating principle of our point-of-care system.
Watch our company presentation here!
Contact
Phone: +49 761 60049600
Email: info@spindiag.de
Spindiag GmbH, Engesserstr. 4a,
79108 Freiburg, Germany